Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Taniguchi

Showing results (691-700 of 703) with videos related to

Pageof 71
Sort By:
Diabetes, Nutrition & Metabolism|November 22, 2001
Lack of association between hepatocyte nuclear factor-1beta gene and common forms of type 2 diabetes in the Japanese populationN Babaya, H Ikegami, T Fujisawa, et al.
British Journal of Cancer|June 13, 2014
Prognostic significance of CD44 variant 2 upregulation in colorectal cancerM Ozawa, Y Ichikawa, Y-W Zheng, et al.
Journal of Comparative Pathology|November 7, 2019
Evaluation of Cytopathological Techniques for the Diagnosis of Canine Visceral Leishmaniosis with Lymph Node SamplesJ M Guerra, N C C A Fernandes, R A Réssio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled studyE Van Cutsem, T Yoshino, H J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsT Yoshino, G Pentheroudakis, S Mishima, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in <i>BRAF</i> V600E-mutated metastatic colorectal cancer: GI-SCREEN <i>post-hoc</i> analysisM Imai, Y Nakamura, T Denda, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
PRABITAS study design: a pragmatic, randomized phase III trial of bi-weekly versus conventional trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancerT Sakakida, T Masuishi, M Asayama, et al.
Journal of Applied Genetics|November 15, 2024
Identification of trait-associated microRNA modules in liver transcriptome of pig fed with PUFAs-enriched supplementary dietC S Pareek, M Sachajko, G Kalra, et al.
ESMO Open|July 4, 2025
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED)Y Shiraishi, T Shimose, Y Tsuchiya-Kawano, et al.
ESMO Open|October 10, 2025
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)T Masuishi, H Taniguchi, D Kotani, et al.
Pageof 71

Showing results (691-700 of 703) with videos related to

Sort By:
Pageof 71
Diabetes, Nutrition & Metabolism|November 22, 2001
Lack of association between hepatocyte nuclear factor-1beta gene and common forms of type 2 diabetes in the Japanese populationN Babaya, H Ikegami, T Fujisawa, et al.
British Journal of Cancer|June 13, 2014
Prognostic significance of CD44 variant 2 upregulation in colorectal cancerM Ozawa, Y Ichikawa, Y-W Zheng, et al.
Journal of Comparative Pathology|November 7, 2019
Evaluation of Cytopathological Techniques for the Diagnosis of Canine Visceral Leishmaniosis with Lymph Node SamplesJ M Guerra, N C C A Fernandes, R A Réssio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled studyE Van Cutsem, T Yoshino, H J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusionsT Yoshino, G Pentheroudakis, S Mishima, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in <i>BRAF</i> V600E-mutated metastatic colorectal cancer: GI-SCREEN <i>post-hoc</i> analysisM Imai, Y Nakamura, T Denda, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
PRABITAS study design: a pragmatic, randomized phase III trial of bi-weekly versus conventional trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancerT Sakakida, T Masuishi, M Asayama, et al.
Journal of Applied Genetics|November 15, 2024
Identification of trait-associated microRNA modules in liver transcriptome of pig fed with PUFAs-enriched supplementary dietC S Pareek, M Sachajko, G Kalra, et al.
ESMO Open|July 4, 2025
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED)Y Shiraishi, T Shimose, Y Tsuchiya-Kawano, et al.
ESMO Open|October 10, 2025
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)T Masuishi, H Taniguchi, D Kotani, et al.
Pageof 71